| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.34 | 0.04 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.04 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.04 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.04 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |